Physician profile
Shashank Srivastava
NPI 1366408221
$15,275.62
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 98% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $616 · 2020: $88.57 · 2021: $17.28 · 2022: $342 · 2023: $26.80 · 2024: $725 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $13K · Food and Beverage: $790 · Travel and Lodging: $21.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $13,400.00 |
| Food and Beverage | $790.39 |
| Travel and Lodging | $21.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $13,418.09 | 2024-2025 | |
| International Life Sciences | $382.34 | 2024 | Flexband |
| Kerecis Limited | $207.82 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Integra Lifesciences Corporation | $197.43 | 2019-2022 | |
| Bioventus LLC | $124.99 | 2022 | |
| Melinta Therapeutics, LLC | $124.97 | 2019 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Medtronic, INC. | $105.52 | 2024 | |
| Mylan Specialty L.P. | $90.76 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $88.57 | 2019 | |
| Organogenesis INC. | $82.27 | 2019-2022 | |
| Tactile Systems Technology INC | $68.68 | 2019 | |
| Horizon Therapeutics Plc | $59.89 | 2019-2020 | |
| Glaxosmithkline, LLC. | $46.33 | 2023-2025 | Trelegy Ellipta |
| Abbvie INC. | $30.19 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $29.49 | 2019-2020 | |
| Amgen INC. | $25.95 | 2024 | Krystexxa |
| Biowound Solutions, INC. | $23.36 | 2025 | Bio-Connekt |
| Philips North America LLC | $22.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.32 | 2019 | |
| Mimedx Group, INC. | $17.16 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashank Srivastava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.